Sponsors (2)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Creates a new federal public health insurance option to be sold on the ACA health insurance Exchanges starting with plan years on or after January 1, 2027. The Department of Health and Human Services must design bronze, silver, and gold qualified plans, set geographically adjusted premiums that fully cover benefits and administration (with a contingency margin), negotiate provider and drug payment rates (with a default to Medicare rates if negotiations fail), and run the option’s finances through a Treasury account with start-up funding that is repaid over ten years.
The bill expands consumer access to a federally operated, affordable-sounding public option and builds infrastructure to run it, but does so while creating meaningful federal fiscal exposure, potential provider participation and access risks from Medicare-equivalent payment defaults, and the possibility of disrupting private insurer competition and plan pricing.
Uninsured individuals and current Exchange enrollees gain access beginning 2027 to a federally offered public option on the ACA Exchanges that aims to be affordable while meeting bronze/silver/gold benefit standards.
Hospitals, health systems, and other providers who participate in Medicare or Medicaid are automatically included in the public option networks unless they opt out, simplifying network participation and helping continuity of care for patients.
If payment negotiations fail, provider and prescription drug payments default to Medicare-equivalent rates, which standardizes payment benchmarks and can limit excessively high payments.
Taxpayers face potentially substantial initial and ongoing costs because start-up funds and reserves are federally financed with authorizations phrased as 'such sums as may be necessary', exposing the federal budget to open-ended obligations.
Defaulting payments to Medicare-equivalent rates could reduce revenues for providers that currently receive higher commercial payments, prompting some providers to limit participation in the public option or reduce services, which could reduce patient access.
A federally administered public option offered exclusively by HHS risks crowding out private insurers on the Exchanges, potentially reducing plan choice and altering market competition with uncertain effects on overall premiums.
Introduced January 8, 2026 by Sheldon Whitehouse · Last progress January 8, 2026